Lexpos News

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection. MSN/2025/021 Tier 2 – medium impact Date of issue: 7th April 2025 Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection are being discontinued with stock [...]

The post Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection. MSN/2025/021 Tier 2 – medium impact Date of issue: 7th April 2025 Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection are being discontinued with stock [...]

The post Medicine Supply Notification: Triamcinolone acetonide 10mg/ml (Adcortyl® ampoules) and 40mg/ml (Kenalog® vials) suspension for injection appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) Date issued: 7 April 2025 Cross Healthcare Limited has informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension. DMRC reference number: DMRC-35184448 Company name: [...]

The post MHRA Class 4 Medicines Notification: Renacet 475 mg and 950 mg tablets (RenaCare NephroMed GmbH) appeared first on Community Pharmacy England.